Sfoglia per Autore
Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival
2022-01-01 Roviello, F.; Marano, L.; Ambrosio, M. R.; Resca, L.; D'Ignazio, A.; Petrelli, F.; Petrioli, R.; Costantini, M.; Polom, K.; Macchiarelli, R.; Biviano, I.; Marrelli, D.
The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer
2022-01-01 Marano, Luigi; Ambrosio, Maria Raffaella; Resca, Luca; Carbone, Ludovico; Carpineto Samorani, Osvaldo; Petrioli, Roberto; Savelli, Vinno; Costantini, Maurizio; Malaspina, Lara; Polom, Karol; Biviano, Ivano; Marrelli, Daniele; Roviello, Franco
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM)
2022-01-01 Mazzei, Maria Antonietta; Bagnacci, Giulio; Gentili, Francesco; Capitoni, Iacopo; Mura, Gianni; Marrelli, Daniele; Petrioli, Roberto; Brunese, Luca; Cappabianca, Salvatore; Catarci, Marco; Degiuli, Maurizio; De Manzoni, Giovanni; De Prizio, Marco; Donini, Annibale; Romario, Uberto Fumagalli; Funicelli, Luigi; Laghi, Andrea; Minetti, Giuseppe; Morgagni, Paolo; Petrella, Enrico; Pittiani, Frida; Rausei, Stefano; Romanini, Laura; Rosati, Riccardo; Ianora, Amato Antonio Stabile; Tiberio, Guido A M; Volterrani, Luca; Roviello, Franco; Grassi, Roberto
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer
2021-01-01 Francini, E.; Ou, F. -S.; Lazzi, S.; Petrioli, R.; Multari, A. G.; Pesola, G.; Messuti, L.; Colombo, E.; Livellara, V.; Bazzurri, S.; Cherri, S.; Miano, S. T.; Wolfe, E. G.; Alberts, S. R.; Hubbard, J. M.; Yoon, H. H.; Francini, G.
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy
2021-01-01 Francini, E.; Montagnani, F.; Nuzzo, P. V.; Gonzalez-Velez, M.; Alimohamed, N. S.; Rosellini, P.; Moreno-Candilejo, I.; Cigliola, A.; Rubio-Perez, J.; Crivelli, F.; Shaw, G. K.; Zhang, L.; Petrioli, R.; Bengala, C.; Francini, G.; Garcia-Foncillas, J.; Sweeney, C. J.; Higano, C. S.; Bryce, A. H.; Harshman, L. C.; Lee-Ying, R.; Heng, D. Y. C.
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer
2021-01-01 Marrelli, D.; Petrioli, R.; Cassetti, D.; D'Ignazio, A.; Marsili, S.; Mazzei, M. A.; Lazzi, S.; Roviello, F.
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients
2020-01-01 Palmieri, M.; Baldassarri, M.; Fava, F.; Fabbiani, A.; Gelli, E.; Tita, R.; Torre, P.; Petrioli, R.; Hadijstilianou, T.; Galimberti, D.; Cinotti, E.; Bengala, C.; Mandala, M.; Piu, P.; Miano, S. T.; Martellucci, I.; Vannini, A.; Pinto, A. M.; Mencarelli, M. A.; Marsili, S.; Renieri, A.; Frullanti, E.
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial
2020-01-01 Monti, M.; Morgagni, P.; Nanni, O.; Framarini, M.; Saragoni, L.; Marrelli, D.; Roviello, F.; Petrioli, R.; Romario, U. F.; Rimassa, L.; Bozzarelli, S.; Donini, A.; Graziosi, L.; De Angelis, V.; De Manzoni, G.; Bencivenga, M.; Mengardo, V.; Parma, E.; Milandri, C.; Mura, G.; Signorini, A.; Baiocchi, G.; Molfino, S.; Sgroi, G.; Steccanella, F.; Rausei, S.; Proserpio, I.; Vigano, J.; Brugnatelli, S.; Rinnovati, A.; Santi, S.; Ercolani, G.; Foca, F.; Valmorri, L.; Amadori, D.; Frassineti, G. L.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
2020-01-01 Roviello, G.; D'Angelo, A.; Petrioli, R.; Roviello, F.; Cianchi, F.; Nobili, S.; Mini, E.; Lavacchi, D.
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study
2020-01-01 Petrioli, R.; Mazzei, M. A.; Giorgi, S.; Cesqui, E.; Gentili, F.; Francini, G.; Volterrani, L.; Francini, E.
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer
2020-01-01 Petrioli, Roberto; Francini, Edoardo; Cherri, Sara; Marrelli, Daniele; Roviello, Franco; Fiaschi, Anna Ida; Miano, Salvatora Tindara; Savelli, Vinno; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Guido
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient
2020-01-01 Miano, S. T.; Francini, E.; Petrioli, R.; Francini, G.
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer
2020-01-01 Petrioli, R.; Torre, P.; Pesola, G.; Paganini, G.; Paolelli, L.; Miano, S. T.; Martellucci, I.; Francini, G.; Francini, E.
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis
2019-01-01 Frullanti, E; Palmieri, M; Baldassarri, M; Fava, F; Fabbiani, A; Gelli, E; Tita, R; Torre, P; Petrioli, R; Hadijstilianou, T; Galimberti, D; Cinotti, E; Mencarelli, Ma; Pinto, Am; Francini, E; Marsili, S; Francini, G; Renieri, A
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer
2019-01-01 Petrioli, R.; Marrelli, D.; Roviello, F.; D'Ignazio, A.; Torre, P.; Chirra, M.; Savelli, V.; Ambrosio, M. R.; Francini, G.; Calomino, N.; Farsi, M.; Vernillo, R.; Francini, E.
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy
2018-01-01 Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer
2018-01-01 Petrioli, R.; Francini, E.; Cherri, S.; Torre, P.; Fiaschi, A. I.; Miano, S. T.; Marrelli, D.; Rovello, F.; Francini, G.
Surgical management of advanced gastric cancer: An evolving issue
2016-01-01 Marano, L; Polom, KAROL ROMAN; Patriti, A; Roviello, Giandomenico; Falco, G; Stracqualursi, A; De Luca, R; Petrioli, Roberto; Martinotti, M; Generali, D; Marrelli, Daniele; Di Martino, N; Roviello, Franco
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis
2016-01-01 DE FRANCO, LORENZO GIACINTO; Marrelli, Daniele; Caputo, Edda; Petrioli, Roberto; Roviello, Giandomenico; Calvanese, A.; Roviello, Franco
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
2016-01-01 Roviello, Giandomenico; Ravelli, Andrea; Polom, KAROL ROMAN; Petrioli, Roberto; Marano, Luigi; Marrelli, Daniele; Roviello, Franco; Generali, Daniele
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival | 1-gen-2022 | Roviello, F.; Marano, L.; Ambrosio, M. R.; Resca, L.; D'Ignazio, A.; Petrelli, F.; Petrioli, R.; Costantini, M.; Polom, K.; Macchiarelli, R.; Biviano, I.; Marrelli, D. | - | |
| The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer | 1-gen-2022 | Marano, Luigi; Ambrosio, Maria Raffaella; Resca, Luca; Carbone, Ludovico; Carpineto Samorani, Osvaldo; Petrioli, Roberto; Savelli, Vinno; Costantini, Maurizio; Malaspina, Lara; Polom, Karol; Biviano, Ivano; Marrelli, Daniele; Roviello, Franco | - | |
| Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) | 1-gen-2022 | Mazzei, Maria Antonietta; Bagnacci, Giulio; Gentili, Francesco; Capitoni, Iacopo; Mura, Gianni; Marrelli, Daniele; Petrioli, Roberto; Brunese, Luca; Cappabianca, Salvatore; Catarci, Marco; Degiuli, Maurizio; De Manzoni, Giovanni; De Prizio, Marco; Donini, Annibale; Romario, Uberto Fumagalli; Funicelli, Luigi; Laghi, Andrea; Minetti, Giuseppe; Morgagni, Paolo; Petrella, Enrico; Pittiani, Frida; Rausei, Stefano; Romanini, Laura; Rosati, Riccardo; Ianora, Amato Antonio Stabile; Tiberio, Guido A M; Volterrani, Luca; Roviello, Franco; Grassi, Roberto | - | |
| The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer | 1-gen-2021 | Francini, E.; Ou, F. -S.; Lazzi, S.; Petrioli, R.; Multari, A. G.; Pesola, G.; Messuti, L.; Colombo, E.; Livellara, V.; Bazzurri, S.; Cherri, S.; Miano, S. T.; Wolfe, E. G.; Alberts, S. R.; Hubbard, J. M.; Yoon, H. H.; Francini, G. | - | |
| Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy | 1-gen-2021 | Francini, E.; Montagnani, F.; Nuzzo, P. V.; Gonzalez-Velez, M.; Alimohamed, N. S.; Rosellini, P.; Moreno-Candilejo, I.; Cigliola, A.; Rubio-Perez, J.; Crivelli, F.; Shaw, G. K.; Zhang, L.; Petrioli, R.; Bengala, C.; Francini, G.; Garcia-Foncillas, J.; Sweeney, C. J.; Higano, C. S.; Bryce, A. H.; Harshman, L. C.; Lee-Ying, R.; Heng, D. Y. C. | - | |
| A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer | 1-gen-2021 | Marrelli, D.; Petrioli, R.; Cassetti, D.; D'Ignazio, A.; Marsili, S.; Mazzei, M. A.; Lazzi, S.; Roviello, F. | - | |
| Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients | 1-gen-2020 | Palmieri, M.; Baldassarri, M.; Fava, F.; Fabbiani, A.; Gelli, E.; Tita, R.; Torre, P.; Petrioli, R.; Hadijstilianou, T.; Galimberti, D.; Cinotti, E.; Bengala, C.; Mandala, M.; Piu, P.; Miano, S. T.; Martellucci, I.; Vannini, A.; Pinto, A. M.; Mencarelli, M. A.; Marsili, S.; Renieri, A.; Frullanti, E. | - | |
| Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial | 1-gen-2020 | Monti, M.; Morgagni, P.; Nanni, O.; Framarini, M.; Saragoni, L.; Marrelli, D.; Roviello, F.; Petrioli, R.; Romario, U. F.; Rimassa, L.; Bozzarelli, S.; Donini, A.; Graziosi, L.; De Angelis, V.; De Manzoni, G.; Bencivenga, M.; Mengardo, V.; Parma, E.; Milandri, C.; Mura, G.; Signorini, A.; Baiocchi, G.; Molfino, S.; Sgroi, G.; Steccanella, F.; Rausei, S.; Proserpio, I.; Vigano, J.; Brugnatelli, S.; Rinnovati, A.; Santi, S.; Ercolani, G.; Foca, F.; Valmorri, L.; Amadori, D.; Frassineti, G. L. | - | |
| Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer | 1-gen-2020 | Roviello, G.; D'Angelo, A.; Petrioli, R.; Roviello, F.; Cianchi, F.; Nobili, S.; Mini, E.; Lavacchi, D. | - | |
| Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study | 1-gen-2020 | Petrioli, R.; Mazzei, M. A.; Giorgi, S.; Cesqui, E.; Gentili, F.; Francini, G.; Volterrani, L.; Francini, E. | - | |
| Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer | 1-gen-2020 | Petrioli, Roberto; Francini, Edoardo; Cherri, Sara; Marrelli, Daniele; Roviello, Franco; Fiaschi, Anna Ida; Miano, Salvatora Tindara; Savelli, Vinno; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Guido | - | |
| A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient | 1-gen-2020 | Miano, S. T.; Francini, E.; Petrioli, R.; Francini, G. | - | |
| Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer | 1-gen-2020 | Petrioli, R.; Torre, P.; Pesola, G.; Paganini, G.; Paolelli, L.; Miano, S. T.; Martellucci, I.; Francini, G.; Francini, E. | - | |
| Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis | 1-gen-2019 | Frullanti, E; Palmieri, M; Baldassarri, M; Fava, F; Fabbiani, A; Gelli, E; Tita, R; Torre, P; Petrioli, R; Hadijstilianou, T; Galimberti, D; Cinotti, E; Mencarelli, Ma; Pinto, Am; Francini, E; Marsili, S; Francini, G; Renieri, A | - | |
| Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer | 1-gen-2019 | Petrioli, R.; Marrelli, D.; Roviello, F.; D'Ignazio, A.; Torre, P.; Chirra, M.; Savelli, V.; Ambrosio, M. R.; Francini, G.; Calomino, N.; Farsi, M.; Vernillo, R.; Francini, E. | - | |
| Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy | 1-gen-2018 | Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo | - | |
| Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer | 1-gen-2018 | Petrioli, R.; Francini, E.; Cherri, S.; Torre, P.; Fiaschi, A. I.; Miano, S. T.; Marrelli, D.; Rovello, F.; Francini, G. | - | |
| Surgical management of advanced gastric cancer: An evolving issue | 1-gen-2016 | Marano, L; Polom, KAROL ROMAN; Patriti, A; Roviello, Giandomenico; Falco, G; Stracqualursi, A; De Luca, R; Petrioli, Roberto; Martinotti, M; Generali, D; Marrelli, Daniele; Di Martino, N; Roviello, Franco | - | |
| 28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis | 1-gen-2016 | DE FRANCO, LORENZO GIACINTO; Marrelli, Daniele; Caputo, Edda; Petrioli, Roberto; Roviello, Giandomenico; Calvanese, A.; Roviello, Franco | - | |
| Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer | 1-gen-2016 | Roviello, Giandomenico; Ravelli, Andrea; Polom, KAROL ROMAN; Petrioli, Roberto; Marano, Luigi; Marrelli, Daniele; Roviello, Franco; Generali, Daniele | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile